Request Legal Help Now - Free

LAWSUITS NEWS & LEGAL INFORMATION

Drugs/Medical Legal News Articles & Interviews

View Lawyer Interviews only

IUD Breakage an Increasing ParaGard Problem

IUD Breakage an Increasing ParaGard Problem October 23, 2020. By Jane Mundy.
New Jersey When NJ gynecologist Carolyn Delucia, MD suggests to NewBeauty readers that “you can go back to your gynecologist any time to get [Paragard IUD] removed,” it makes you wonder what bubble she is living in. Since 2010, the FDA has received more than 1,600 reports of ParaGard breakage, with more than 700 classified as serious.
Read [ IUD Breakage an Increasing ParaGard Problem ]

Looks like New Jersey hosts Elmiron MDL

Looks like New Jersey hosts Elmiron MDL October 20, 2020. By Jane Mundy.
Newark, NJ It’s a toss-up: whether to send 80 Elmiron vision loss lawsuits to Pennsylvania or New Jersey. Currently the latter seems to be the best bet. Lawyers have so far filed 80 Elmiron lawsuits and they anticipate hundreds more.
Read [ Looks like New Jersey hosts Elmiron MDL ]

C.R. Bard Hernia Mesh Trial Gets the Green Light

C.R. Bard Hernia Mesh Trial Gets the Green Light October 18, 2020. By Jane Mundy.
Santa Clara, CA Federal hernia mesh lawsuits filed against C.R. Bard are proceeding with the first bellwhether trial scheduled for January 2021 (it was postponed due to COVID), despite numerous efforts by the medical device maker to have the case dismissed. This trial may well indicate the future of hernia mesh litigation and significantly impact up to 10,000 pending hernia mesh cases.
Read [ C.R. Bard Hernia Mesh Trial Gets the Green Light ]

Injectafer Double Dose—Double Profit and Double Risk, and Dosage Discrepancy

Injectafer Double Dose—Double Profit and Double Risk, and Dosage Discrepancy October 14, 2020. By Jane Mundy.
Santa Clara, CA Hypophosphatemia, an abnormally low level of phosphate in the blood, may be due to longer term or excess of certain drugs such as bisphosphonates, including Injectafer, but that may depend upon researchers conducting the clinical trials and the amount of the iron-deficiency drug treatment.
Read [ Injectafer Double Dose—Double Profit and Double Risk, and Dosage Discrepancy ]

Textured Breast Implants from Six More Manufacturers Linked to BIA-ALCL

Textured Breast Implants from Six More Manufacturers Linked to BIA-ALCL October 1, 2020. By Anne Wallace.
Washington, DC  A recently published study links breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) to implants manufactured by seven pharmaceutical companies. In addition to Allergan, the manufacturer of Biocell textured breast implants, the study names Mentor Worldwide, a unit of Johnson & Johnson, Silimed Polyurethane, Eurosilicone, Nagor, Orion, and Poly Implant Prothèse. Allergan faces at least 150 product liability and class action lawsuits. Mentor faces a smaller number, and none of the others are yet facing litigation.
Read [ Textured Breast Implants from Six More Manufacturers Linked to BIA-ALCL ]

Paragard Problem with Breaking Leads to More Lawsuits

Paragard Problem with Breaking Leads to More Lawsuits September 28, 2020. By Jane Mundy.
New York, NY Five more women have recently filed lawsuits against Cooper Surgical and Teva Pharmaceuticals claiming its ParaGard IUD broke while being removed. The ParaGard website warns consumers that its device sometimes gets stuck in the uterus, requiring surgical removal, but does not include a problem with it breaking apart.
Read [ Paragard Problem with Breaking Leads to More Lawsuits ]

More Elmiron Lawsuits, including Canada Class Actions, and the Impact of Vision Loss

More Elmiron Lawsuits, including Canada Class Actions, and the Impact of Vision Loss September 28, 2020. By Jane Mundy.
Santa Clara, CA More Elmiron lawsuits are being filed in the U.S. and Canada has filed two class action lawsuits, all alleging the interstitial cystitis drug can cause permanent vision damage.
Read [ More Elmiron Lawsuits, including Canada Class Actions, and the Impact of Vision Loss ]

ETHICON SURGICAL STAPLERS RECALLED AFTER REPORTS OF SERIOUS MEDICAL HARM

ETHICON SURGICAL STAPLERS RECALLED AFTER REPORTS OF SERIOUS MEDICAL HARM September 25, 2020. By Anne Wallace.
Somerville, NJ In mid-October 2019, the FDA recalled Ethicon Echelon Flex surgical staplers because of a dangerous manufacturing failure that could cause serious health damage or even death. This followed, by only a few months, a recall of Ethicon Endo-Surgery curved intraluminal staplers, a defective medical product that posed similar dangers to patients.
Read [ ETHICON SURGICAL STAPLERS RECALLED AFTER REPORTS OF SERIOUS MEDICAL HARM ]

FDA Update on BIA-ALCL Finds More Cases, More Deaths

FDA Update on BIA-ALCL Finds More Cases, More Deaths September 15, 2020. By Anne Wallace.
Silver Spring, MD  On August 20, the U.S. Food and Drug Administration provided an update on adverse events relating to breast implants, including breast implant-associated anaplastic large cell lymphoma. The new FDA update on BIA-ALCL reports a total of 733 cases and 36 patient deaths globally, an increase of 160 new cases and 3 deaths since July 2019. Of those 733 cases, 84.6 percent involved Allergan implants.
Read [ FDA Update on BIA-ALCL Finds More Cases, More Deaths ]

Bayer to Settle Essure Birth Control Lawsuits for $1.6 Billion

Bayer to Settle Essure Birth Control Lawsuits for $1.6 Billion September 11, 2020. By Jane Mundy.
Santa Clara, CA Almost two years after Bayer stopped selling Essure in the U.S., and four years after the FDA told Bayer its birth control device needed a black box warning regarding potential serious side effects, the pharma giant will pay $1.6 billion to settle Essure lawsuits brought by nearly 39,000 women in the U.S. who suffered serious health complications as a result of Essure fallopian tube implants.
Read [ Bayer to Settle Essure Birth Control Lawsuits for $1.6 Billion ]

Page: 1  2  3  4  5  6  7  8  9  -  10»  -  100»  -  124   Next»

Request Legal Help Now! - Free